OBJECTIVE: To document obstacles to completing outpatient treatment faced by indigent patients with cervical cancer and compare treatment costs. METHODS: A retrospective pilot case series study assessed all indigent Harris County residents referred from Lyndon Baines Johnson Hospital (LBJ) to The University of Texas M. D. Anderson Cancer Center (M. D. Anderson) for advanced cervical cancer treatment between February 2001 and April 2004. Twenty-seven patients required hospital admission during the expected course of outpatient treatment and were identified as the study group. Nine patients, drawn from the same cohort but able to successfully complete the expected course of treatment as outpatients, were selected as the control group. RESULTS: The median total treatment costs per patient in the study group (n = 27) was 28,892 US dollar more than the median treatment costs for the patients in the control group (n = 9) (P = 0.01). Median number of inpatient days in the study group was 19.6. Social factors identified as significantly different between the study and control groups included transportation difficulties (P = 0.006) and lack of social support (P = 0.08). Additional factors identified in the study group may have social significance such as accessible local housing (11% vs. 0%, P = 0.56) and noncompliance with treatment (37% vs. 11%, P = 0.22). CONCLUSION: A combination of the lack of adequate methods of transportation and social support may contribute to the high cost of treating indigent patients with cervical cancer in Harris County, Texas.
OBJECTIVE: To document obstacles to completing outpatient treatment faced by indigent patients with cervical cancer and compare treatment costs. METHODS: A retrospective pilot case series study assessed all indigent Harris County residents referred from Lyndon Baines Johnson Hospital (LBJ) to The University of Texas M. D. Anderson Cancer Center (M. D. Anderson) for advanced cervical cancer treatment between February 2001 and April 2004. Twenty-seven patients required hospital admission during the expected course of outpatient treatment and were identified as the study group. Nine patients, drawn from the same cohort but able to successfully complete the expected course of treatment as outpatients, were selected as the control group. RESULTS: The median total treatment costs per patient in the study group (n = 27) was 28,892 US dollar more than the median treatment costs for the patients in the control group (n = 9) (P = 0.01). Median number of inpatient days in the study group was 19.6. Social factors identified as significantly different between the study and control groups included transportation difficulties (P = 0.006) and lack of social support (P = 0.08). Additional factors identified in the study group may have social significance such as accessible local housing (11% vs. 0%, P = 0.56) and noncompliance with treatment (37% vs. 11%, P = 0.22). CONCLUSION: A combination of the lack of adequate methods of transportation and social support may contribute to the high cost of treating indigent patients with cervical cancer in Harris County, Texas.
Authors: Lisa P Spees; Wendy R Brewster; Mahesh A Varia; Morris Weinberger; Christopher Baggett; Xi Zhou; Victoria M Petermann; Stephanie B Wheeler Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-02-07 Impact factor: 4.254
Authors: Anna Louise Beavis; Awa Sanneh; Rebecca L Stone; Margaret Vitale; Kimberly Levinson; Anne F Rositch; Amanda Nickles Fader; Kristin Topel; Ashley Abing; Stephanie L Wethington Journal: Am J Obstet Gynecol Date: 2020-05-17 Impact factor: 8.661
Authors: Lois M Ramondetta; Larissa A Meyer; Kathleen M Schmeler; Maria E Daheri; Jessica Gallegos; Michael Scheurer; Jane R Montealegre; Andrea Milbourne; Matthew L Anderson; Charlotte C Sun Journal: Gynecol Oncol Date: 2015-10-21 Impact factor: 5.482
Authors: Lisa P Spees; Stephanie B Wheeler; Mahesh Varia; Morris Weinberger; Christopher D Baggett; Xi Zhou; Victoria M Petermann; Wendy R Brewster Journal: Gynecol Oncol Date: 2018-11-12 Impact factor: 5.482
Authors: Uma D Goyal; Paras P Mehta; Susan Samreth; John Gloss; Haiyan Cui; Denise Roe; Shona Dougherty Journal: J Contemp Brachytherapy Date: 2021-05-13